Paper35023331
Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.
Li L and 7 others. Adv Sci (Weinh), 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis. Papers, record 35023331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35023331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Experimental | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Animals | |
| Cytokines | |
| Inflammation | |
| Infrared Rays | |
| Rats |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22071130 | National Natural Science Foundation of China | PubMed | ||
| 21871160 | National Natural Science Foundation of China | PubMed | ||
| 21672121 | National Natural Science Foundation of China | PubMed | ||
| 61905130 | National Natural Science Foundation of China | PubMed | ||
| GCCRCYJ039 | High-level talent introduction program at The Eighth Affiliated Hospital of Sun Yat-sen University | PubMed | ||
| 2018M640145 | China Postdoctoral Science Foundation | PubMed | ||
| 2019T120106 | China Postdoctoral Science Foundation | PubMed | ||
| Tsinghua University Postdoctoral Support Program and Center for Life Sciences Outstanding Postdoctoral Foundation | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32601335 | Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. | Nat Med | 2020 | https://conductscience.org/library/papers/32601335 | PubMed |
| 2 | 32033937 | Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. | Ann Rheum Dis | 2020 | https://conductscience.org/library/papers/32033937 | PubMed |
| 3 | 34285414 | Anti-inflammatory TNF receptor 2 signalling unravelled. | Nat Rev Rheumatol | 2021 | https://conductscience.org/library/papers/34285414 | PubMed |
| 4 | 25599189 | Temporal full-colour tuning through non-steady-state upconversion. | Nat Nanotechnol | 2015 | https://conductscience.org/library/papers/25599189 | PubMed |
| 5 | 28612747 | Pathogenetic insights from the treatment of rheumatoid arthritis. | Lancet | 2017 | https://conductscience.org/library/papers/28612747 | PubMed |
| 6 | 30366684 | Rheumatoid arthritis and depression: an inflammatory perspective. | Lancet Psychiatry | 2019 | https://conductscience.org/library/papers/30366684 | PubMed |
| 7 | 29859232 | Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate. | J Control Release | 2018 | https://conductscience.org/library/papers/29859232 | PubMed |
| 8 | 23755969 | Therapies for active rheumatoid arthritis after methotrexate failure. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23755969 | PubMed |
| 9 | 25522972 | PEDOT nanocomposites mediated dual-modal photodynamic and photothermal targeted sterilization in both NIR I and II window. | Biomaterials | 2015 | https://conductscience.org/library/papers/25522972 | PubMed |
| 10 | 29700991 | A New Treatment Modality for Rheumatoid Arthritis: Combined Photothermal and Photodynamic Therapy Using Cu7.2 S4 Nanoparticles. | Adv Healthc Mater | 2018 | https://conductscience.org/library/papers/29700991 | PubMed |
| 11 | 32207921 | Surfactant-Free, Self-Assembled Nanomicelles-Based Transdermal Hydrogel for Safe and Targeted Delivery of Methotrexate against Rheumatoid Arthritis. | ACS Nano | 2020 | https://conductscience.org/library/papers/32207921 | PubMed |
| 12 | 16683808 | High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/16683808 | PubMed |
| 13 | 32743864 | Tocilizumab-Conjugated Polymer Nanoparticles for NIR-II Photoacoustic-Imaging-Guided Therapy of Rheumatoid Arthritis. | Adv Mater | 2020 | https://conductscience.org/library/papers/32743864 | PubMed |
| 14 | 26656659 | Cytokines in rheumatoid arthritis - shaping the immunological landscape. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/26656659 | PubMed |
| 15 | 33733490 | Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations. | Adv Mater | 2021 | https://conductscience.org/library/papers/33733490 | PubMed |
| 16 | 28511143 | DNA-assisted upconversion nanoplatform for imaging-guided synergistic therapy and laser-switchable drug detoxification. | Biomaterials | 2017 | https://conductscience.org/library/papers/28511143 | PubMed |
| 17 | 25990290 | Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/25990290 | PubMed |
| 18 | 34480835 | Attenuation of Rheumatoid Arthritis Through the Inhibition of Tumor Necrosis Factor-Induced Caspase 3/Gasdermin E-Mediated Pyroptosis. | Arthritis Rheumatol | 2022 | https://conductscience.org/library/papers/34480835 | PubMed |
| 19 | 32189997 | The Role of Inflammation in the Pathogenesis of Osteoarthritis. | Mediators Inflamm | 2020 | https://conductscience.org/library/papers/32189997 | PubMed |
| 20 | 11867103 | Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis. | Lancet | 2002 | https://conductscience.org/library/papers/11867103 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42563363 | Stimuli-Responsive Nanoplatforms for Precision Intervention in Rheumatoid Arthritis. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/42563363 | PubMed |
| 42544244 | Theranostic Nanoprobes for Rheumatoid Arthritis: From Inflammation Visualization to Guided Precision Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42544244 | PubMed |
| 42502719 | Synovial microenvironment and fluorescence imaging for early rheumatoid arthritis diagnosis. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42502719 | PubMed |
| 40660434 | Recent Advancement in Drug Delivery Systems for the Treatment of Rheumatoid Arthritis. | Curr Drug Discov Technol | 2026 | https://conductscience.org/library/papers/40660434 | PubMed |
| 39034407 | Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39034407 | PubMed |
| 37985923 | Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/37985923 | PubMed |
| 36461720 | Dual-Triggered Near-Infrared Persistent Luminescence Nanoprobe for Autofluorescence-Free Imaging-Guided Precise Therapy of Rheumatoid Arthritis. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/36461720 | PubMed |
| 36144709 | Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis. | Molecules | 2022 | https://conductscience.org/library/papers/36144709 | PubMed |
| 35508896 | Regulation of Nucleotide Metabolism with Nutrient-Sensing Nanodrugs for Cancer Therapy. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35508896 | PubMed |
| 35023331 | Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35023331 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35023331
GET https://conductscience.org/api/papers/v1/35023331/references?page=2